[Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers].
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D014612:Vaccines
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D014612:Vaccines
Posibilităţi şi perspective ale imunoprofilaxiei şi imunoterapiei infecţiilor piocianice în condiţiile supravegherii acestor infecţii prin markeri epidemiologici.